Nexien BioPharma, Inc.
NXEN
$0.0095
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -50.00% | -72.38% | -88.03% | -81.37% | -96.23% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | 5.00% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -50.00% | -77.38% | -90.26% | -75.43% | -96.62% |
|
|
|||||
| Total Current Assets | -50.00% | -77.38% | -90.26% | -75.43% | -96.62% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -50.00% | -77.38% | -90.26% | -75.43% | -96.62% |
|
|
|||||
| Total Accounts Payable | 100.55% | 90.00% | 125.42% | 98.66% | 70.89% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 25.13% | 18.56% | 15.03% | 10.86% | 8.72% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 33.84% | 26.78% | 23.82% | 17.71% | 13.43% |
|
|
|||||
| Total Current Liabilities | 33.84% | 26.78% | 23.82% | 17.71% | 13.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 25.13% | 18.56% | 15.03% | 10.86% | 8.72% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 33.84% | 26.78% | 23.82% | 17.71% | 13.43% |
|
|
|||||
| Common Stock & APIC | 0.93% | 1.18% | 1.64% | 1.85% | 1.95% |
| Retained Earnings | -1.85% | -1.73% | -2.12% | -2.20% | -2.45% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -34.53% | -34.73% | -43.33% | -41.25% | -55.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.53% | -34.73% | -43.33% | -41.25% | -55.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.53% | -34.73% | -43.33% | -41.25% | -55.31% |
|
|
|||||